X-153182511-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000356661.7(MAGEA1):c.122G>A(p.Gly41Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000207 in 1,209,581 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000090 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000022 ( 0 hom. 7 hem. )
Consequence
MAGEA1
ENST00000356661.7 missense
ENST00000356661.7 missense
Scores
1
8
Clinical Significance
Conservation
PhyloP100: 0.0550
Genes affected
MAGEA1 (HGNC:6796): (MAGE family member A1) This gene is a member of the MAGEA gene family. The members of this family encode proteins with 50 to 80% sequence identity to each other. The promoters and first exons of the MAGEA genes show considerable variability, suggesting that the existence of this gene family enables the same function to be expressed under different transcriptional controls. The MAGEA genes are clustered at chromosomal location Xq28. They have been implicated in some hereditary disorders, such as dyskeratosis congenita. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.12443009).
BS2
High Hemizygotes in GnomAdExome4 at 7 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAGEA1 | NM_004988.5 | c.122G>A | p.Gly41Asp | missense_variant | 3/3 | ENST00000356661.7 | NP_004979.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAGEA1 | ENST00000356661.7 | c.122G>A | p.Gly41Asp | missense_variant | 3/3 | 1 | NM_004988.5 | ENSP00000349085 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000895 AC: 1AN: 111715Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33913
GnomAD3 genomes
AF:
AC:
1
AN:
111715
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
33913
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000820 AC: 15AN: 182992Hom.: 0 AF XY: 0.0000591 AC XY: 4AN XY: 67682
GnomAD3 exomes
AF:
AC:
15
AN:
182992
Hom.:
AF XY:
AC XY:
4
AN XY:
67682
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000219 AC: 24AN: 1097866Hom.: 0 Cov.: 32 AF XY: 0.0000193 AC XY: 7AN XY: 363240
GnomAD4 exome
AF:
AC:
24
AN:
1097866
Hom.:
Cov.:
32
AF XY:
AC XY:
7
AN XY:
363240
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000895 AC: 1AN: 111715Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33913
GnomAD4 genome
AF:
AC:
1
AN:
111715
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
33913
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 12, 2023 | The c.122G>A (p.G41D) alteration is located in exon 3 (coding exon 1) of the MAGEA1 gene. This alteration results from a G to A substitution at nucleotide position 122, causing the glycine (G) at amino acid position 41 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
LIST_S2
Benign
T
MetaRNN
Benign
T
PROVEAN
Uncertain
D
Sift
Benign
T
Sift4G
Benign
T
Vest4
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at